Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Azur Pharma Ltd.

Division of Jazz Pharmaceuticals PLC
www.azurpharma.com

Latest From Azur Pharma Ltd.

Scrip 100: Robust M&A momentum continues to build

Merger & acquisition (M&A) activity among pharmaceutical and bioscience companies has shown no signs of slowing down. More importantly, even though AstraZeneca's rejection of Pfizer's $120bn plus takeover overture has meant that 2014 cannot boast the largest ever M&A deal, the number of $10bn transactions this year has still surpassed that of 2012 and 2013.

Cancer Orthopedics

Jazz Tunes Up For Business Development

With a highly competitive effective tax rate, half a billion dollars in cash, and access to attractively priced capital, specialty pharma Jazz, itself the subject of takeover rumors, has stepped up its ongoing hunt for late-stage assets.

BioPharmaceutical Business Strategies

Teva Cited For Promo Suggesting 14-Year Old Schizophrenia Study Shows Clozapine Superiority

FDA says Teva’s promotional piece misleadingly implies clozapine is superior to olanzapine, risperidone and haloperidol in improving one symptom cluster.

BioPharmaceutical Regulation

Jazz And Concert In Tune On Xyrem

The two biotech companies have teamed up to create a follow-on product to Jazz’s narcolepsy drug, a collaboration that could add to the patent-life of Xyrem and be financially beneficial for both companies.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • Jazz Pharmaceuticals PLC
  • Senior Management
  • Seamus Mulligan, Chmn. & CEO
    David Brabazon, SVP, Fin. & CFO
  • Contact Info
  • Azur Pharma Ltd.
    Phone: (353) 1-634 4183
    45 Fitzwilliam Sq.
    Dublin 2,
    Ireland
Advertisement
Advertisement
UsernamePublicRestriction

Register